Tag:
AlloCure
Latest Headlines
Latest Headlines
Lundbeckfond contributes to $25M B round for AlloCure's Phase II stem cell study
Lundbeckfond Ventures has stepped in to lead a $25 million venture round for AlloCure, a Burlington, MA-based stem cell company.
Stem cell player moves to Mass.
The adult stem cell therapy developer AlloCure has moved from Salt Lake City all the way to Burlington, MA. Lean and mean with fewer than 10 workers, AlloCure also has a new CEO: Robert Brenner. "If
